Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 381

1.

STAT5A and STAT5B-Twins with Different Personalities in Hematopoiesis and Leukemia.

Maurer B, Kollmann S, Pickem J, Hoelbl-Kovacic A, Sexl V.

Cancers (Basel). 2019 Nov 4;11(11). pii: E1726. doi: 10.3390/cancers11111726. Review.

2.

A lot on her plate.

Maurer BT.

JAAPA. 2019 Oct;32(10):58. doi: 10.1097/01.JAA.0000580548.71969.7d. No abstract available.

PMID:
31567745
4.

Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual.

Fasano S, Riccardi A, Messiniti V, Caramaschi P, Rosato E, Maurer B, Smith V, Siegert E, De Langhe E, Riccieri V, Airó P, Mihai C, Avouac J, Zanatta E, Walker UA, Iannone F, García De la Peña Lefebvre P, Distler JHW, Vacca A, Distler O, Kowal-Bielecka O, Allanore Y, Valentini G.

Ann Rheum Dis. 2019 Dec;78(12):1681-1685. doi: 10.1136/annrheumdis-2019-215787. Epub 2019 Aug 17.

PMID:
31422354
5.

Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.

Javaheri T, Kazemi Z, Pencik J, Pham HTT, Kauer M, Noorizadeh R, Sax B, Nivarthi H, Schlederer M, Maurer B, Hofbauer M, Aryee DNT, Wiedner M, Tomazou EM, Logan M, Hartmann C, Tuckermann JP, Kenner L, Mikula M, Dolznig H, Üren A, Richter GH, Grebien F, Kovar H, Moriggl R.

Cell Death Dis. 2019 Aug 13;10(8):605. doi: 10.1038/s41419-019-1853-1.

6.

Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study.

Valentini G, Huscher D, Riccardi A, Fasano S, Irace R, Messiniti V, Matucci-Cerinic M, Guiducci S, Distler O, Maurer B, Avouac J, Tarner IH, Frerix M, Riemekasten G, Siegert E, Czirják L, Lóránd V, Denton CP, Nihtyanova S, Walker UA, Jaeger VK, Del Galdo F, Abignano G, Ananieva LP, Gherghe AM, Mihai C, Henes JC, Schmeiser T, Vacca A, Moiseev S, Foeldvari I, Gabrielli A, Krummel-Lorenz B, Rednic S, Allanore Y, Müeller-Ladner U.

Ann Rheum Dis. 2019 Nov;78(11):1576-1582. doi: 10.1136/annrheumdis-2019-215486. Epub 2019 Aug 7.

PMID:
31391176
7.

[Systemic sclerosis-clinical picture, diagnosis, and treatment].

Becker MO, Distler O, Maurer B.

Hautarzt. 2019 Sep;70(9):723-741. doi: 10.1007/s00105-019-4454-0. German.

PMID:
31384958
8.

Partnering with a parent.

Maurer BT.

JAAPA. 2019 Aug;32(8):58. doi: 10.1097/01.JAA.0000569812.31411.de. No abstract available.

PMID:
31348105
9.

Quantitative CT texture analysis for diagnosing systemic sclerosis: Effect of iterative reconstructions and radiation doses.

Milanese G, Mannil M, Martini K, Maurer B, Alkadhi H, Frauenfelder T.

Medicine (Baltimore). 2019 Jul;98(29):e16423. doi: 10.1097/MD.0000000000016423.

10.

Regulation of Fibroblast Apoptosis and Proliferation by MicroRNA-125b in Systemic Sclerosis.

Kozlova A, Pachera E, Maurer B, Jüngel A, Distler JHW, Kania G, Distler O.

Arthritis Rheumatol. 2019 Jul 16. doi: 10.1002/art.41041. [Epub ahead of print]

PMID:
31309742
11.

When care goes beyond the patient.

Maurer BT.

JAAPA. 2019 Jul;32(7):58. doi: 10.1097/01.JAA.0000558384.16481.f3. No abstract available.

PMID:
31241614
12.

Erratum to the impact of slice-reduced computed tomography on histogram based densitometry assessment of lung fibrosis in patients with systemic sclerosis.

Nguyen-Kim TDL, Maurer B, Suliman YA, Morsbach F, Distler O, Frauenfelder T.

J Thorac Dis. 2019 Apr;11(4):E69. doi: 10.21037/jtd.2019.03.84.

13.

Impact of liposomal bupivacaine on opioid use, hospital length of stay, discharge status, and hospitalization costs in patients undergoing total hip arthroplasty.

Asche CV, Dagenais S, Kang A, Ren J, Maurer BT.

J Med Econ. 2019 Jun 21:1-8. doi: 10.1080/13696998.2019.1627363. [Epub ahead of print]

PMID:
31161837
14.

Reliability and validity of the German version of the Myositis Activities Profile (MAP) in patients with inflammatory myopathy.

Baschung Pfister P, de Bruin ED, Bastiaenen CHG, Maurer B, Knols RH.

PLoS One. 2019 Jun 3;14(6):e0217173. doi: 10.1371/journal.pone.0217173. eCollection 2019.

15.

High activation of STAT5A drives peripheral T-cell lymphoma and leukemia.

Maurer B, Nivarthi H, Wingelhofer B, Pham HTT, Schlederer M, Suske T, Grausenburger R, Schiefer AI, Prchal-Murphy M, Chen D, Winkler S, Merkel O, Kornauth C, Hofbauer M, Hochgatterer B, Hoermann G, Hoelbl-Kovacic A, Prochazkova J, Lobello C, Cumaraswamy AA, Latzka J, Kitzwögerer M, Chott A, Janikova A, Pospíšilova Š, Loizou JI, Kubicek S, Valent P, Kolbe T, Grebien F, Kenner L, Gunning PT, Kralovics R, Herling M, Müller M, Rülicke T, Sexl V, Moriggl R.

Haematologica. 2019 May 23. pii: haematol.2019.216986. doi: 10.3324/haematol.2019.216986. [Epub ahead of print]

16.

Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study.

Blagojevic J, Abignano G, Avouac J, Cometi L, Frerix M, Bellando-Randone S, Guiducci S, Bruni C, Huscher D, Jaeger VK, Lóránd V, Maurer B, Nihtyanova S, Riemekasten G, Siegert E, Tarner IH, Vettori S, Walker UA, Czirják L, Denton CP, Distler O, Allanore Y, Müller-Ladner U, Moggi-Pignone A, Matucci-Cerinic M, Del Galdo F; EUSTAR co-workers.

Clin Rheumatol. 2019 May 20. doi: 10.1007/s10067-019-04564-8. [Epub ahead of print]

PMID:
31111363
17.

[Systemic sclerosis-clinical picture, diagnosis, and treatment].

Becker MO, Distler O, Maurer B.

Z Rheumatol. 2019 Jun;78(5):439-457. doi: 10.1007/s00393-019-0639-2. German.

PMID:
31089800
18.

A slice of life.

Maurer BT.

JAAPA. 2018 Apr;31(4):58. doi: 10.1097/01.JAA.0000531055.35373.08. No abstract available.

PMID:
30973537
19.

STAT5BN642H drives transformation of NKT cells: a novel mouse model for CD56+ T-LGL leukemia.

Klein K, Witalisz-Siepracka A, Maurer B, Prinz D, Heller G, Leidenfrost N, Prchal-Murphy M, Suske T, Moriggl R, Sexl V.

Leukemia. 2019 Sep;33(9):2336-2340. doi: 10.1038/s41375-019-0471-3. Epub 2019 Apr 9. No abstract available.

20.

Keeping one step ahead of the need to know.

Maurer BT.

JAAPA. 2019 Apr;32(4):58. doi: 10.1097/01.JAA.0000554229.01995.e5. No abstract available.

PMID:
30913153
21.

Hydrophilic interaction liquid chromatography-tandem mass spectrometric approach for simultaneous determination of safingol and D-erythro-sphinganine in human plasma.

Cho HE, Maurer BJ, Reynolds CP, Kang MH.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Apr 1;1112:16-23. doi: 10.1016/j.jchromb.2019.02.023. Epub 2019 Feb 22.

PMID:
30836314
22.

Enhanced recovery of low concentration protein and peptide solutions on ultra-low binding microplates.

Weikart CM, Breeland AP, Taha AH, Maurer BR.

Future Sci OA. 2019 Jan 25;5(2):FSO367. doi: 10.4155/fsoa-2018-0099. eCollection 2019 Feb.

23.

Falling through the cracks: A matter of substance.

Maurer BT.

JAAPA. 2019 Mar;32(3):58. doi: 10.1097/01.JAA.0000553387.67637.16. No abstract available.

PMID:
30817484
24.

Release of Immunomodulatory Ebola Virus Glycoprotein-Containing Microvesicles Is Suppressed by Tetherin in a Species-Specific Manner.

Nehls J, Businger R, Hoffmann M, Brinkmann C, Fehrenbacher B, Schaller M, Maurer B, Schönfeld C, Kramer D, Hailfinger S, Pöhlmann S, Schindler M.

Cell Rep. 2019 Feb 12;26(7):1841-1853.e6. doi: 10.1016/j.celrep.2019.01.065.

25.

Water molecules in protein-ligand interfaces. Evaluation of software tools and SAR comparison.

Nittinger E, Gibbons P, Eigenbrot C, Davies DR, Maurer B, Yu CL, Kiefer JR, Kuglstatter A, Murray J, Ortwine DF, Tang Y, Tsui V.

J Comput Aided Mol Des. 2019 Mar;33(3):307-330. doi: 10.1007/s10822-019-00187-y. Epub 2019 Feb 12.

PMID:
30756207
26.

Twins with different personalities: STAT5B-but not STAT5A-has a key role in BCR/ABL-induced leukemia.

Kollmann S, Grundschober E, Maurer B, Warsch W, Grausenburger R, Edlinger L, Huuhtanen J, Lagger S, Hennighausen L, Valent P, Decker T, Strobl B, Mueller M, Mustjoki S, Hoelbl-Kovacic A, Sexl V.

Leukemia. 2019 Jul;33(7):1583-1597. doi: 10.1038/s41375-018-0369-5. Epub 2019 Jan 24.

27.

Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) survey.

Blagojevic J, Bellando-Randone S, Abignano G, Avouac J, Cometi L, Czirják L, Denton CP, Distler O, Frerix M, Guiducci S, Huscher D, Jaeger VK, Lóránd V, Maurer B, Nihtyanova S, Riemekasten G, Siegert E, Tarner IH, Vettori S, Walker UA, Allanore Y, Müller-Ladner U, Del Galdo F, Matucci-Cerinic M; EUSTAR co-workers.

Arthritis Res Ther. 2019 Jan 24;21(1):35. doi: 10.1186/s13075-019-1822-1.

28.

CDK6 coordinates JAK2 V617F mutant MPN via NF-κB and apoptotic networks.

Uras IZ, Maurer B, Nivarthi H, Jodl P, Kollmann K, Prchal-Murphy M, Milosevic Feenstra JD, Zojer M, Lagger S, Grausenburger R, Grabner B, Holly R, Kavirayani A, Bock C, Gisslinger H, Valent P, Kralovics R, Sexl V.

Blood. 2019 Apr 11;133(15):1677-1690. doi: 10.1182/blood-2018-08-872648. Epub 2019 Jan 11.

29.

Therapeutic Vulnerabilities in FLT3-Mutant AML Unmasked by Palbociclib.

Uras IZ, Maurer B, Nebenfuehr S, Zojer M, Valent P, Sexl V.

Int J Mol Sci. 2018 Dec 11;19(12). pii: E3987. doi: 10.3390/ijms19123987.

30.

A Christmas gift.

Maurer BT.

JAAPA. 2018 Dec;31(12):58. doi: 10.1097/01.JAA.0000547752.15805.a4. No abstract available.

PMID:
30489394
31.

Visualisation of interstitial lung disease by molecular imaging of integrin αvβ3 and somatostatin receptor 2.

Schniering J, Benešová M, Brunner M, Haller S, Cohrs S, Frauenfelder T, Vrugt B, Feghali-Bostwick CA, Schibli R, Distler O, Mueller C, Maurer B.

Ann Rheum Dis. 2019 Feb;78(2):218-227. doi: 10.1136/annrheumdis-2018-214322. Epub 2018 Nov 17. Erratum in: Ann Rheum Dis. 2019 Jun;78(6):e60.

32.

Impact of treatment with liposomal bupivacaine on hospital costs, length of stay, and discharge status in patients undergoing total knee arthroplasty at high-use institutions.

Asche CV, Dagenais S, Kang A, Ren J, Maurer BT.

J Med Econ. 2018 Oct 31:1-10. doi: 10.1080/13696998.2018.1543190. [Epub ahead of print]

PMID:
30378454
33.

Abnormal esophageal motility during a solid test meal in systemic sclerosis-detection even in very early disease and association with disease progression.

Bütikofer S, Jordan S, Sauter M, Hollenstein M, Heinrich H, Freitas-Queiroz N, Kuntzen T, Ang D, Oberacher M, Maurer B, Schwizer W, Fox M, Distler O, Misselwitz B.

Neurogastroenterol Motil. 2019 Jan;31(1):e13480. doi: 10.1111/nmo.13480. Epub 2018 Oct 1.

PMID:
30276930
34.

Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia.

Song MM, Makena MR, Hindle A, Koneru B, Nguyen TH, Verlekar DU, Cho H, Maurer BJ, Kang MH, Reynolds CP.

Anticancer Drugs. 2019 Feb;30(2):117-127. doi: 10.1097/CAD.0000000000000696.

PMID:
30272587
35.

In Vivo Labeling of Plasma Proteins for Imaging of Enhanced Vascular Permeability in the Lungs.

Schniering J, Borgna F, Siwowska K, Benešová M, Cohrs S, Hasler R, van der Meulen NP, Maurer B, Schibli R, Müller C.

Mol Pharm. 2018 Nov 5;15(11):4995-5004. doi: 10.1021/acs.molpharmaceut.8b00606. Epub 2018 Sep 28.

PMID:
30265552
36.

Making it up as you go along.

Maurer BT.

JAAPA. 2018 Oct;31(10):58. doi: 10.1097/01.JAA.0000545083.26377.8e. No abstract available.

PMID:
30252767
37.

Evaluation of 99mTc-rhAnnexin V-128 SPECT/CT as a diagnostic tool for early stages of interstitial lung disease associated with systemic sclerosis.

Schniering J, Guo L, Brunner M, Schibli R, Ye S, Distler O, Béhé M, Maurer B.

Arthritis Res Ther. 2018 Aug 16;20(1):183. doi: 10.1186/s13075-018-1681-1.

38.

When the dust settles.

Maurer BT.

JAAPA. 2018 Aug;31(8):58. doi: 10.1097/01.JAA.0000541485.39363.2c. No abstract available.

PMID:
30048359
39.

Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.

Javaheri T, Kazemi Z, Jan Pencik, Pham HTT, Kauer M, Noorizadeh R, Sax B, Nivarthi H, Schlederer M, Maurer B, Hofbauer M, Aryee DNT, Wiedner M, Tomazou EM, Logan M, Hartmann C, Tuckermann JP, Kenner L, Mikula M, Dolznig H, Üren A, Richter GH, Grebien F, Kovar H, Moriggl R.

Cell Death Dis. 2018 Jul 23;9(8):800. doi: 10.1038/s41419-018-0773-9.

40.

Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model.

Wu W, Jordan S, Becker MO, Dobrota R, Maurer B, Fretheim H, Ye S, Siegert E, Allanore Y, Hoffmann-Vold AM, Distler O.

Ann Rheum Dis. 2018 Sep;77(9):1326-1332. doi: 10.1136/annrheumdis-2018-213201. Epub 2018 Jun 6.

PMID:
29875097
41.

The impact of slice-reduced computed tomography on histogram-based densitometry assessment of lung fibrosis in patients with systemic sclerosis.

Nguyen-Kim TDL, Maurer B, Suliman YA, Morsbach F, Distler O, Frauenfelder T.

J Thorac Dis. 2018 Apr;10(4):2142-2152. doi: 10.21037/jtd.2018.04.39. Erratum in: J Thorac Dis. 2019 Apr;11(4):E69.

42.

Do you believe in magic?

Maurer BT.

JAAPA. 2018 Jun;31(6):58. doi: 10.1097/01.JAA.0000533663.88073.5c. No abstract available.

PMID:
29846318
43.

Correction: Determining carnivore habitat use in a rubber/forest landscape in Brazil using multispecies occupancy models.

Dechner A, Flesher KM, Lindell C, Veiga de Oliveira T, Maurer BA.

PLoS One. 2018 May 9;13(5):e0197397. doi: 10.1371/journal.pone.0197397. eCollection 2018.

44.

Determining carnivore habitat use in a rubber/forest landscape in Brazil using multispecies occupancy models.

Dechner A, Flesher KM, Lindell C, Veiga de Oliveira T, Maurer BA.

PLoS One. 2018 Apr 16;13(4):e0195311. doi: 10.1371/journal.pone.0195311. eCollection 2018. Erratum in: PLoS One. 2018 May 9;13(5):e0197397.

45.

Manual muscle testing and hand-held dynamometry in people with inflammatory myopathy: An intra- and interrater reliability and validity study.

Baschung Pfister P, de Bruin ED, Sterkele I, Maurer B, de Bie RA, Knols RH.

PLoS One. 2018 Mar 29;13(3):e0194531. doi: 10.1371/journal.pone.0194531. eCollection 2018.

46.

Pharmacologic inhibition of STAT5 in acute myeloid leukemia.

Wingelhofer B, Maurer B, Heyes EC, Cumaraswamy AA, Berger-Becvar A, de Araujo ED, Orlova A, Freund P, Ruge F, Park J, Tin G, Ahmar S, Lardeau CH, Sadovnik I, Bajusz D, Keserű GM, Grebien F, Kubicek S, Valent P, Gunning PT, Moriggl R.

Leukemia. 2018 May;32(5):1135-1146. doi: 10.1038/s41375-017-0005-9. Epub 2018 Feb 2.

47.

Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL.

Schrader A, Crispatzu G, Oberbeck S, Mayer P, Pützer S, von Jan J, Vasyutina E, Warner K, Weit N, Pflug N, Braun T, Andersson EI, Yadav B, Riabinska A, Maurer B, Ventura Ferreira MS, Beier F, Altmüller J, Lanasa M, Herling CD, Haferlach T, Stilgenbauer S, Hopfinger G, Peifer M, Brümmendorf TH, Nürnberg P, Elenitoba-Johnson KSJ, Zha S, Hallek M, Moriggl R, Reinhardt HC, Stern MH, Mustjoki S, Newrzela S, Frommolt P, Herling M.

Nat Commun. 2018 Feb 15;9(1):697. doi: 10.1038/s41467-017-02688-6.

48.

Father wounds: Dealing with loss.

Maurer BT.

JAAPA. 2018 Feb;31(2):58. doi: 10.1097/01.JAA.0000529776.83273.bf. No abstract available.

PMID:
29369934
49.

Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna et al.

Lilleker JB, Vencovsky J, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, Jordan P, Benveniste O, Danieli MG, Dankó K, Phuong Thuy NT, Vázquez-Del Mercado M, Andersson H, Paepe B, De Bleecker JL, Maurer B, McCann LJ, Pipitone N, McHugh N, Betteridge Z, New P, Cooper RG, Ollier WE, Lamb JA, Krogh NS, Lundberg IE, Chinoy H; all EuroMyositis contributors.

Ann Rheum Dis. 2018 Aug;77(8):e51. doi: 10.1136/annrheumdis-2017-212382. Epub 2017 Dec 19. No abstract available.

PMID:
29259048
50.

Weekend call: Sifting the salient points.

Maurer BT.

JAAPA. 2017 Dec;30(12):58. doi: 10.1097/01.JAA.0000526789.57518.fb. No abstract available.

PMID:
29210913

Supplemental Content

Loading ...
Support Center